Siolas Lab

Publications

Found 10 results
Filters: First Letter Of Last Name is K  [Clear All Filters]
2005
Silva JM, Li MZ, Chang K, Ge W, Golding MC, Rickles RJ, Siolas D, Hu G, Paddison PJ, Schlabach MR et al..  2005.  Second-generation shRNA libraries covering the mouse and human genomes.. Nat Genet. 37(11):1281-8.
2021
Siolas D, Vucic E, Kurz E, Hajdu C, Bar-Sagi D.  2021.  Gain-of-function p53R172H mutation drives accumulation of neutrophils in pancreatic tumors, promoting resistance to immunotherapy.. Cell Rep. 36(8):109578.
2023
Kasi PMurtaza, Hidalgo M, Jafari MD, Yeo H, Lowenfeld L, Khan U, Nguyen ATH, Siolas D, Swed B, Hyun J et al..  2023.  Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer.. Oncogene. 42(44):3252-3259.
Kasi PMurtaza, Hidalgo M, Jafari MD, Yeo H, Lowenfeld L, Khan U, Nguyen ATH, Siolas D, Swed B, Hyun J et al..  2023.  Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer.. Oncogene. 42(44):3252-3259.
Kasi PMurtaza, Hidalgo M, Jafari MD, Yeo H, Lowenfeld L, Khan U, Nguyen ATH, Siolas D, Swed B, Hyun J et al..  2023.  Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer.. Oncogene. 42(44):3252-3259.
Wan S, Zhao E, Weissinger D, Krantz BA, Werba G, Freeman D, Khanna LG, Siolas D, Oberstein PE, Chattopadhyay PK et al..  2023.  Tumor infiltrating T cell states and checkpoint inhibitor expression in hepatic and pancreatic malignancies.. Front Immunol. 14:1067352.
Wan S, Zhao E, Weissinger D, Krantz BA, Werba G, Freeman D, Khanna LG, Siolas D, Oberstein PE, Chattopadhyay PK et al..  2023.  Tumor infiltrating T cell states and checkpoint inhibitor expression in hepatic and pancreatic malignancies.. Front Immunol. 14:1067352.
2025
Bogdani C, Karimi A, Atkinson E, Li R, Oberstein PE, Siolas D.  2025.  Circulating Tumor DNA Monitoring in Peptide Receptor Radionuclide Therapy–Treated Patients with Gastrointestinal Neuroendocrine Tumors. In revision.
Bogdani C, Karimi A, Siolas D.  2025.  Durable Remission in BRCA2-Mutated, PD-L1-Overexpressing Pancreatic Cancer with Multimodal Precision Therapy: A Case Report. In press.
Karimi A, Bogdani C, O’Dwyer E, Siolas D.  2025.  Emerging Innovations in Theranostics for Pancreatic Neuroendocrine Tumors.. npj Precision Oncology.